Adma Biologics Inc (ADMA)

Cost of Revenue

$180.81M

TTM · Period ending: · USD

ADMA logo

ADMA Cost of Revenue

Latest reported$180.81M
ADMA TTM Cost of Revenue ($0.00 → $180.81M)
High-resolution chart · PNG

ADMA cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adma Biologics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
180,806,000
197,445,000
217,407,000
221,276,000
222,858,000
217,839,000
206,901,000
195,502,255
177,944,255
171,639,255
169,273,255
162,260,379
151,071,875
133,774,489
118,814,535
105,881,538
94,743,255
87,440,265
79,769,341
76,009,066
67,569,317
62,232,322
61,291,426
53,871,922
49,932,678
46,928,285
39,504,238
38,954,751
40,202,640
39,357,066
42,194,635
42,975,418
45,102,425
39,790,782
29,164,321
19,255,750
9,700,405
6,710,627
6,360,761
5,849,168
5,226,179
4,668,253
4,311,461
3,765,567
3,520,466
3,674,966
3,742,367
3,067,915
2,926,479
2,471,425
2,023,441
2,121,347
1,539,793
1,195,902
666,856
291,040
147,674
5,804
6,864
3,764
3,233
3,233
2,173
794
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.